 Early diagnosis specialist BioAffinity NASDAQ: BIAF spiked 60 on Wednesday morning before paring back some gains in the afternoon to around 40 up. Investors piled into BIAF stock upon the underlying company disclosing the receipt of approximately 7.7 million in additional gross proceeds from its initial public offering IPO. 